We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
1. Pulmonary oedema occurs when pulmonary capillary membrane permeability or hydrostatic pressure is increased.
2. Pulmonary oedema is categorised as either cardiogenic or non-cardiogenic, and early diagnosis of the underlying cause is key.
3. Patients with cardiogenic pulmonary oedema secondary to acute heart failure are often hypovolaemic/euvolaemic, and treatment with diuretics is associated with increased mortality, myocardial infarction and the need for mechanical ventilation. Vasodilators and prompt consideration of non-invasive ventilation are advised.
4. In patients with cardiogenic shock secondary to chronic decompensated heart failure, diuresis and prompt consideration of non-invasive ventilation are advised.
5. In patients with non-cardiogenic pulmonary oedema, the role of non-invasive ventilation is less clear and early endotracheal intubation should be considered.
The applications of non-invasive ventilation (NIV) include: acute exacerbation of chronic obstructive pulmonary disease (COPD) and cardiogenic pulmonary oedema, for immunocompromised patient, during failure to wean from ventilation. It is essential before NIV is initiated that arterial blood gas measurements be available. The patient should be established upon appropriate oxygen therapy and interpretation must be made in the context of the FiO2. Correct patient selection is essential for the success of NIV: it is a complementary not alternative therapy to IPPV. The successful instigation of NIV is very dependent upon establishing a good rapport with the patient and inspiring confidence in what will feel like a very unusual treatment. The complications of NIV include mild gastric distension, pressure effects of the mask and straps causing facial tissue damage, eye irritation, sinus pain or nasal congestion, and significant haemodynamic effects resulting from NIV that are unusual although hypotension may occur.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.